The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Hypothyroidism in Pregnancy: Consequences to Neonatal Health
Open accessAbstract
Pregnancy influences thyroid function in multiple ways. Not only does the maternal hypothalamic-pituitary-thyroid (HPT) axis undergo a series of adjustments, the fetus develops its own HPT axis and the placenta plays an active role in iodide and T4 transport and metabolism. Thus, an integrated three-compartment thyroid model exists during gestation (1). Early in pregnancy estrogen promotes production of a more highly sialylated T4-binding globulin isoform that is less rapidly degraded, resulting in increased serum T4-binding globulin and T4 concentrations (1–3). Although a transient decrease in serum free T4, followed by a rise in TSH to a new equilibrium, may occur (3), this is usually not appreciated with routine thyroid testing. A high circulating CG level in the first trimester leads to CG cross-reactivity with the TSH receptor, prompting a temporary increase in free T4 and partial suppression of TSH. The final physiologic change results from placental deiodination of maternal T4, which increases T4 turnover. In normal pregnant women, the thyroid gland maintains euthyroidism with only minor fluctuations in serum T4 and TSH. However, in women with limited thyroid reserve, due to thyroid autoimmunity or iodine deficiency, hypothyroidism can develop (Fig. 1). Physiologic and nutritional influences on maternal thyroid function (see Refs. 2 and 3 for review). The sizes of the circles do not imply relative importance of each biochemical or physiologic pathway. Fetal thyroid ontogeny begins at 10–12 weeks gestation and is not complete until delivery; T4 is not secreted until 18–20 weeks (1, 3). T4 is critical for many aspects of brain development including neurogenesis, neuronal migration, axon and dendrite formation, myelination, synaptogenesis, and neurotransmitter regulation (4). Although these requirements evolve over months (5), an especially critical time is the second trimester (6). Contrary to past belief, thyroid hormone crosses the placenta. Animal studies have shown that maternal T4 reaches the fetus (5). T4 has been measured in human coelomic fluid as early as 4 weeks gestation (7) and is detectable in cord blood of newborns with athyreosis or thyroid dysgenesis (8). Abnormal thyroid gland function may be restricted to the fetus, the expectant mother, or both (Table 1). Fetal hypothyroidism can be permanent or transient. When transient, it results from transplacental passage of autoantibodies or drugs, or to immaturity of the HPT axis in premature infants. Combined maternal and fetal hypothyroidism is almost always due to iodine deficiency (2, 3, 6), but thyroid-binding inhibitory immunoglobulin (TBII) has been implicated on occasion (9). Severe maternal hypothyroidism is not common, but mild thyroid failure in which the serum TSH is elevated with a normal free T4 level has been reported in 2.5% of pregnancies (10). Causes of maternal and fetal hypothyroidism Causes of maternal and fetal hypothyroidism The impact of severe iodine deficiency or congenital hypothyroidism on the fetus and newborn is profound, as are the effects of overt maternal hypothyroidism on pregnancy. The severity, timing of onset and duration, as well as postnatal management, all influence fetal and neonatal brain development. It is now believed than even mild maternal hypothyroidism (from mild iodine deficiency, thyroid autoimmunity, or thyroid under-replacement) may affect fetal brain development. The implications of this finding are yet to be clearly defined, but have raised many questions that need resolution. Fetal hypothyroidism. Congenital hypothyroidism (CH) affects approximately 1 in 4000 newborns. Eighty-five percent are sporadic cases of thyroid dysgenesis. Next in frequency are genetic disorders, with reported mutations of the genes for PAX-8, thyroid transcription factor 2, TPO, thyroglobulin, sodium-iodide symporter, and others (9). Before the early 1970s, 40% of children with CH required special education. Neonatal screening programs are now implemented throughout the industrialized world and have reduced the need for special education to only 10% of CH children (11). A meta-analysis of seven studies showed a significant decrease of 6.3 IQ points in 675 CH children vs. 570 controls (12). The severity and duration of fetal hypothyroidism reflect the level of intellectual impairment, and can be assessed by serum T4 and skeletal maturation at birth. Those newborns with T4 less than 2 μg/dL and knee bone surface area less than 0.05 cm2 have IQs in childhood that are 12–16 points lower than those with milder CH (9). Derksen-Lubsen and Verkerk (12) suggested that “at least part of the brain damage in patients with CH is caused in utero and cannot be prevented by early treatment.” However, two changes in management, earlier treatment, and higher dose l-thyroxine therapy may abrogate or ameliorate any impact of thyroid hormone deficiency on intellectual development (9, 11). Rovet (4) reported the long-term outcome in a g
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Glinoer, D. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0300 · Cited by 1,364
Maternal and Fetal Thyroid Function
Epstein, F. H., Burrow, G. N., Fisher, D. A., & Larsen, P. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311608 · Cited by 720
Increased need for thyroxine during pregnancy in women with primary hypothyroidism
Mandel, S. J., Larsen, P. R., Seely, E. W., & Brent, G. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230204 · Cited by 360
Cited by
Role of thyroid hormone during early brain development
Morreale de Escobar, G., Obregon, M., & Escobar del Rey, F. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u025 · Cited by 831
Hypothyroidism in Context: Where We’ve Been and Where We’re Going
Chiovato, L., Magri, F., & Carlé, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01080-8 · Cited by 459
Thyroid autoimmunity and hypothyroidism before and during pregnancy
Poppe, K. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg012 · Cited by 306
Muller, A. F., Drexhage, H. A., & Berghout, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0441 · Cited by 289
Glinoer, D. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.03.001 · Cited by 285
Metadata
- Authors
- Smallridge, R. C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-06-01
- Volume
- 86
- Issue
- 6
- Pages
- 2349-2353
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2154447174
- Cited by
- 196
- References
- 4
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypothyroidism in Pregnancy: Consequences to Neonatal Health. https://app.cochat.ai/papers/10.1210/jc.86.6.2349
- The paper
- Smallridge, R. C. (2001). Hypothyroidism in Pregnancy: Consequences to Neonatal Health. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.86.6.2349
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.